FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "RXQ Compounding, LLC(079640811)" | 70731-906 | 70731-906-30 | Ascorbic Acid; Glutathione | 20 mg/1 mL; 200 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-971 | 70731-971-10 | Ascorbic Acid; Glutathione | 20 mg/1 mL; 200 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-976 | 70731-976-30 | Niacinamide; Riboflavin 5'-Phosphate Sodium; Dexpanthenol; Thiamine Hydrochloride; Pyridoxine Hydrochloride | 100 mg/1 mL; 2.54 mg/1 mL; 5 mg/1 mL; 100 mg/1 mL; 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-961 | 70731-961-82 | Niacinamide; Riboflavin 5'-Phosphate Sodium; Dexpanthenol; Thiamine Hydrochloride; Pyridoxine Hydrochloride | 100 mg/1 mL; 2.54 mg/1 mL; 5 mg/1 mL; 100 mg/1 mL; 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-136 | 70731-136-86 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-238 | 70731-238-41 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-957 | 70731-957-50 | Sodium Bicarbonate | 84 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-176 | 70731-176-05 | Zinc Sulfate; Calcium Gluconate Monohydrate; Magnesium Chloride | 1 mg/1 mL; 6 mg/1 mL; 200 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-201 | 70731-201-85 | Ephedrine Sulfate | 5 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-231 | 70731-231-86 | Epinephrine | 10 ug/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-118 | 70731-118-55 | Fentanyl Citrate | .05 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-246 | 70731-246-55 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "RXQ Compounding, LLC(079640811)" | 70731-246 | 70731-246-82 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | Morphine Sulfate | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Morphine Sulfate | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-16 | Morphine Sulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-59 | Morphine Sulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-62 | Morphine Sulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-18 | Morphine Sulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-63 | Morphine Sulfate | 1 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | Ropivacaine Hydrochloride | 2 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Dibasic Potassium Phosphate; Monobasic Potassium Phosphate | 1180 mg/1 mL; 1120 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | "vasopressin, Unspecified" | 20 U | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-211 | 70004-211-16 | Fentanyl Citrate | .05 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-211 | 70004-211-06 | Fentanyl Citrate | .05 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-211 | 70004-211-30 | Fentanyl Citrate | .05 mg/1 mL | 2020-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .025 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .025 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Acetaminophen | 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Acetaminophen | 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Acetaminophen | 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-322 | 70004-322-18 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2020-2 | valid | 2026-11-12 |